Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dropbox Inc (DBX) vs Eli Lilly And Co (LLY) Price & Performance

Dropbox IncTrade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

Dropbox Inc vs Eli Lilly And Co — how do they compare? Dropbox Inc trades at $29.53 (market cap $6.99B), while Eli Lilly And Co trades at $1,153.8 (market cap $1.03T). The key difference: Eli Lilly And Co is far larger — about 147.4× Dropbox Inc's market cap, and Eli Lilly And Co pays a 0.6% dividend while Dropbox Inc pays none. Which is the better fit depends on your goals.

DBXLLY
Market Cap
$6.99B$1.03T
Sector
TechnologyHealth
52-Week High
$32.17$1.24K
52-Week Low
$22.06$625.65
Enterprise Value
$9.71B$1.07T
Dividend Yield
0.6%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dropbox Inc

Dropbox (DBX) trades at $29.58, up 1.34% on the day, near the analyst consensus price target of $30. The stock shows a bullish technical trend with strong moving average signals, though RSI levels indicate potential overbought conditions. Fundamentally, the company maintains robust profitability with a net income margin of 18.71% and has beaten earnings estimates for three consecutive quarters. Recent news highlights a new $900 million stock repurchase program and a CEO transition plan announced in May 2026.

The outlook is balanced with solid fundamentals and shareholder returns offset by high debt levels and mixed analyst sentiment. Investment appeal lies in consistent earnings beats and capital return initiatives, but risks include elevated leverage and competitive pressures in cloud storage. The stock presents a moderate opportunity with cautious optimism warranted given its valuation near target prices.

Eli Lilly And Co

Eli Lilly (LLY) trades at $1,185.08, down slightly (-0.29%) on the day, with a strong bullish technical signal from moving averages. The company demonstrates exceptional fundamental strength, with revenue surging to $65.18B in 2025 and a net income margin of 34.99%. Recent earnings have consistently beaten expectations, and analyst sentiment is overwhelmingly positive, with a consensus price target of $1,360.

The outlook for LLY remains robust, driven by its dominant position in the high-growth weight loss and Alzheimer's drug markets. Key opportunities include continued revenue expansion and pipeline advancements. Primary risks involve intensifying competition, particularly from Novo Nordisk's obesity pill, and the stock's premium valuation multiples, which demand sustained high growth to justify.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Dropbox Inc

Dropbox is a leading provider of cloud-storage and content collaboration tools with an emphasis on individuals and SMB. The company was founded in 2007 and was a pioneer in cloud storage and cross-platform file syncing. Utilizing inorganic and organic means, the firm has been working on diversifying its product mix and pivoting away from the cloud-storage space.

Read more on DBX

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY